Experts say FDA officials and doctors should treat hormone therapy like any other drug that has both benefits and risks, and remember that hormones aren’t the only options for treating menopausal ...
Novo Nordisk ((NVO)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to ...
Pediatric growth hormone deficiency (GHD) is a relatively rare condition, affecting an estimated 1 in 4,000- 10,000 children. Despite its rarity, GHD can significantly impact a child’s growth and ...
Women taking elinzanetant had a nearly 74% improvement in hot flashes and night sweats The pill contains no estrogen, so could help women who don’t want hormone therapy THURSDAY, Sept. 25, 2025 ...
The addition of the hormone progesterone to gender-affirming hormone therapy leads to increased breast growth for transgender people following feminizing hormone therapy. This is demonstrated by an ...
Department of Endocrinology, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China Background: The treatment of idiopathic short stature (ISS) with recombinant human growth hormone (rhGH) ...
The FDA has approved the once-weekly injectable lonapegsomatropin-tcgd (Skytrofa, Ascendis Pharma A/S) for replacing endogenous growth hormone in adults with growth hormone deficiency (GHD), expanding ...
Lonapegsomatropin statistically significantly reduced trunk percent fat at week 38 compared with placebo (-1.7% vs 0.4%, respectively) in adult GHD patients. The Food and Drug Administration (FDA) has ...
A birth control pill designed for men that temporarily pauses the production of sperm, with no hormones required, has passed its first safety trial. The landmark birth control pill is spurring ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback